← Browse by Condition
Medical Condition

astrocytoma idh mutant

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05879367 Phase 1
Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Enrollment
66 pts
Location
United States
Sponsor
Orbus Therapeutics, Inc.
View Trial →